Related Experiment Video
Updated: Jun 28, 2026
Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module
Published on: June 18, 2015
Antiestrogen, trans-tamoxifen modulation of human breast cancer cell growth
Abstract:
To gain further insight into how antiestrogens modulate cell function, the effects of antiestrogen on cell proliferation were studied in human breast cancer cells. We examined the effects of trans-tamoxifen on the proliferation of three human breast cancer cell lines that differed in their estrogen receptor contents. Trans-tamoxifen (1 muM) markedly inhibited the estrogen stimulated proliferation of MCF-7 human breast cancer cells that contained high levels of estrogen receptor (1.15+/-0.03 pmole/mg protein) over that of control. In T47D cells that contained low levels of estrogen receptor (0.23+/-0.05 pmole/mg protein), trans-tamoxifen (1 muM) showed minimal inhibition of estrogen stimulated cell proliferation over that of control. MDA-MB-231 cells, that contained no detectable levels of estrogen receptors, had their growth unaffected by trans-tamoxifen treatment. These results showed their sensitivity to growth inhibition by antiestrogen correlated well with their estrogen receptor content. Also we activator activity in MCF-7 cells. Trans-tamoxifen (1 muM) showed maximal inhibition of estrogen stimulated progestrone receptor level as well as plasminogen activator activity in MCF-7 cells that were stimulated by estrogen. It is not clear whether these inhibitions of progestrone receptor and plasminogen activator activity by estrogen are related to the antiestrogen inhibition of cell proliferation of MCF-7 cells. From the results of this study, it is clearly demonstrated that trans-tamoxifen is an antiestrogen in MCF-7 human breast cancer cells. Our data suggest that the biological effectiveness of trans-tamoxifen appear to result from its affinity of interaction with the estrogen receptor.
Insights
Trans-tamoxifen effectively inhibits estrogen-stimulated proliferation in human breast cancer cells, with effectiveness directly correlating to estrogen receptor levels. This antiestrogen
Area of Science:
- Oncology
- Endocrinology
- Molecular Biology
Background:
- Antiestrogens are crucial in modulating cell function, particularly in hormone-dependent cancers.
- Understanding antiestrogen mechanisms is key to developing targeted cancer therapies.
Purpose of the Study:
- To investigate the effects of trans-tamoxifen on human breast cancer cell proliferation.
- To determine the correlation between estrogen receptor (ER) content and antiestrogen sensitivity.
Main Methods:
- Examined trans-tamoxifen's effect on three human breast cancer cell lines (MCF-7, T47D, MDA-MB-231) with varying ER levels.
- Measured cell proliferation and estrogen receptor content.
- Assessed effects on progesterone receptor and plasminogen activator activity.
Main Results:
- Trans-tamoxifen markedly inhibited proliferation in ER-rich MCF-7 cells.
- Minimal inhibition was observed in low-ER T47D cells.
- MDA-MB-231 cells, lacking ER, showed no growth inhibition.
- Inhibition of proliferation correlated directly with estrogen receptor content.
Conclusions:
- Trans-tamoxifen acts as an antiestrogen in MCF-7 cells.
- The biological effectiveness of trans-tamoxifen is linked to its estrogen receptor binding affinity.
- Estrogen receptor status is a critical determinant of antiestrogen efficacy in breast cancer treatment.
More Related Videos
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
06:54Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Related Concept Videos
02:38Mitogens and the Cell Cycle
03:03mTOR Signaling and Cancer Progression
The mTOR pathway or the...